Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SillaJen Inc (215600 KS)
Watchlist
52
Analysis
Health Care
•
South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
SillaJen Inc
•
25 Mar 2024 19:40
SillaJen Rights Offering Worth 34% of Outstanding Shares
On 22 March, SillaJen announced that it will conduct a rights offering worth about 129 billion. The rights offering size is 34.5 million shares,...
Douglas Kim
Follow
562 Views
Share
bullish
•
KG Mobility
•
11 May 2023 03:28
Overlooked Aspects of KG Mobility's Passive Flow Trading Opportunities: KOSPI 200 & KRX Auto
In this post, I will explore the overlooked passive flow trading opportunities offered by KG Mobility. Specifically, I will focus on trading...
Sanghyun Park
Follow
499 Views
Share
bearish
•
HPSP
•
30 Dec 2022 17:35
End of Mandatory Lock-Up Periods for 57 Companies in Korea in January 2023
We discuss end of the mandatory lock-up periods for 57 stocks in Korea in January 2023, among which 5 are in KOSPI and 52 are in KOSDAQ.
Douglas Kim
Follow
912 Views
Share
bearish
•
HYBE
•
30 Nov 2022 18:43
End of Mandatory Lock-Up Periods for 58 Companies in Korea in December 2022
We discuss end of the mandatory lock-up periods for 58 stocks in Korea in December 2022, among which 9 are in KOSPI and 49 are in KOSDAQ.
Douglas Kim
Follow
691 Views
Share
bearish
•
Devsisters
•
17 Nov 2022 04:55
KOSDAQ150 Index Rebalance: 11 Changes with a Couple of Surprises
There are 11 changes at the Dec rebal: mostly in line with forecasts. SillaJen is a surprise add; Devsisters is a surprise delete. Short interest...
Brian Freitas
Follow
696 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x